miquelangeles
Member
- Joined
- Mar 18, 2021
- Messages
- 928
The real question is how do they determine whether the virus they have detected is active, dead, or just broken up pieces of the dead virus. This would be the real question as to whether that person, has, did have, or is recovering from infection.
The next question would be how do they treat the disease if the person has tested positive for the virus in an early detection scenario?
This is not really relevant to the thread's topic as long as they apply the same methodology (flawed or not) to both vaccinated and unvaccinated people. It is aggregated data per 100k population.
Why are there significantly more "cases" in the vaccinated? Is the body still producing spike proteins long after the vaccine administration and giving "false positives" on tests? The reason why CDC lowered the cycle threshold?
Or is it because most of the unvaccinated are incrementally achieving long lasting herd immunity naturally whereas the vaccine efficacy incrementally wanes off?
Or are they really getting AIDS?
The UK now uses Ronapreve (a combination of monoclonals administered by IV) and this is the reason they have so few deaths despite the huge number of cases. The gov calls it a "groundbreaking new treatment". I believe it has to be administered in the first 72hrs from a positive test to be effective. Monoclonal antibodies are basically vaccines minus clots & myocarditis. It's the same antibodies and the half-life is 30 days, meaning they offer protection for several months, exactly how the vaccines were designed too.